Recent SEC filings document the extension of the business combination deadline, auditor change, and liquidity position as of December 31, 2025.

• On February 28, 2025, the company extended the deadline to consummate a business combination from March 3, 2025, to December 31, 2025, as approved by stockholders [S1].
• On March 21, 2025, the company changed its independent registered public accounting firm from Marcum LLP to CBIZ CPAs P.C. with no disagreements or reportable events noted [S1].
• As of December 31, 2025, the company reported cash and cash equivalents of $196,869, current assets of $254,467, current liabilities of $6,069,540, a current ratio of 0.04, and net income of $556,003 [S1].

The company maintains a significant cash position relative to liabilities, providing liquidity to pursue a business combination. The extension of the deadline to complete a business combination allows additional time to identify suitable targets. The change in auditors was completed without disagreements, indicating stable financial reporting processes.

The company has a very low current ratio, indicating potential liquidity constraints relative to current liabilities. The absence of disclosed operational business details and revenue limits visibility into future prospects. Risks related to trade policy changes could reduce the pool of viable business combination targets or adversely affect a post-combination company. The material weakness in internal controls over financial reporting presents ongoing risk to financial accuracy and compliance.

As a SPAC, Concord Acquisition Corp II does not currently operate a traditional business with competitive advantages or economic moats. Its value proposition depends on successfully identifying and completing a business combination with a target company, which is subject to market and execution risks.

• Liquidity Risk: The company reported a current ratio of 0.04 as of December 31, 2025, indicating current liabilities significantly exceed current assets, which may constrain operational flexibility.
• Business Combination Execution Risk: The company must identify and complete a business combination by the extended deadline of December 31, 2025, or earlier as determined by the board, which carries execution risk.
• Trade Policy and Tariff Risk: Changes in international trade policies and tariffs may negatively impact the attractiveness of potential business combination targets or the performance of a post-combination company.
• Internal Control Weakness: A material weakness in internal control over financial reporting related to accounting for complex financial instruments has been disclosed, which may affect financial reporting reliability.

• Concord Acquisition Corp II is a special purpose acquisition company (SPAC) registered in Delaware.
• The company trades under ticker CNDA on OTCQX, with related securities including units (CNDAU) and warrants (CNDAW).
• As of December 31, 2025, the company reported cash and cash equivalents of $196,869 and current assets of $254,467, with current liabilities of $6,069,540, resulting in a current ratio of 0.04 and a cash ratio of 46.2, indicating a liquidity structure heavily weighted towards cash relative to liabilities.
• The company reported net income of $556,003 for the fiscal year ended December 31, 2025.
• The company extended the deadline to consummate a business combination from March 3, 2025, to December 31, 2025, as approved by stockholders.
• The company changed its independent registered public accounting firm from Marcum LLP to CBIZ CPAs P.C. in March 2025, with no disagreements or reportable events noted in the transition.
• The company is classified as an emerging growth company under SEC rules.
• No revenue, segment, or detailed operational business information is disclosed in the latest SEC filings.
• Risk factors disclosed include potential material adverse effects from changes in international trade policies and tariffs that could impact the search for a business combination target or the post-combination company.
• The company has a material weakness in internal control over financial reporting related to accounting for complex financial instruments, as disclosed in prior annual reports.